Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Jul 27, 2024; 16(7): 2047-2053
Published online Jul 27, 2024. doi: 10.4240/wjgs.v16.i7.2047
Published online Jul 27, 2024. doi: 10.4240/wjgs.v16.i7.2047
Retrospective analysis based on a clinical grading system for patients with hepatic hemangioma: A single center experience
Cheng-Ming Zhou, Jun Cao, Tuerhongjiang Tuxun, Shadike Apaer, Jin-Ming Zhao, Department of Liver and Laparoscopic Surgery, Digestive and Vascular Surgery Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, Xinjiang Uygur Autonomous Region, China
Shao-Ke Chen, Department of Operation Management, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, Xinjiang Uygur Autonomous Region, China
Jing Wu, Department of General Surgery, The First Teaching College, Xinjiang Medical University, Urumqi 830054, Xinjiang Uygur Autonomous Region, China
Hao Wen, State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, Xinjiang Uygur Autonomous Region, China
Author contributions: Zhou CM was responsible for data collection and analyses, and writing of the original draft; Cao J and Wu J contributed to data collection and analyses; Chen SK performed supervision, formal analysis, validation, and data curation; Tuxun T and Apaer S revised the manuscript; Zhao JM and Wen H reviewed and approved the final manuscript; and all authors have read and approved the final manuscript.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University.
Informed consent statement: Patients were apprised of their rights to informed consent and provided with a written informed consent for participation in this study.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hao Wen, PhD, Professor, State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, The First Affiliated Hospital of Xinjiang Medical University, No. 137 Liyushan South Road, Xinshi District, Urumqi 830054, Xinjiang Uygur Autonomous Region, China. dr.wenhao@163.com
Received: February 25, 2024
Revised: May 14, 2024
Accepted: June 13, 2024
Published online: July 27, 2024
Processing time: 147 Days and 20.2 Hours
Revised: May 14, 2024
Accepted: June 13, 2024
Published online: July 27, 2024
Processing time: 147 Days and 20.2 Hours
Core Tip
Core Tip: With the development of surgical technique and new intervention including transcatheter arterial embolization and radiofrequency ablation used in liver surgery, the incidence of postoperative complications has been significantly decreased, however, the treatment of hepatic hemangioma still needs to consider the balance of benefit and risk, surgical indications for hepatic hemangioma remain unclear. Here, we evaluate a clinical grading system for management of hepatic hemangioma based on our 17 years of experience. The clinical grading system combined with the individual situation of patients could be helpful to select the most appropriate treatment for these lesions.